PREX1 and non-small cell lung carcinoma: Furthermore, PREX1 knockdown significantly reversed the promotion of growth in the xenograft tumors in vivo by FOSB overexpression in NSCLC cells (Fig. 6D), which was further validated by the decrease in Ki67 expression (Fig. 6E), a well-established molecular marker of cell proliferation [40].